targetId,strataId,cohortId,cohortType,name
1,1,1000011,TwS,Newly diagnosed prostate cancer with Age < 60
2,1,2000011,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with Age < 60
3,1,3000011,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with Age < 60
4,1,4000011,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with Age < 60
5,1,5000011,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with Age < 60
7,1,7000011,TwS,Treatment category: prostatectomy surgery with Age < 60
8,1,8000011,TwS,Treatment category: radiotherapy with Age < 60
9,1,9000011,TwS,Treatment category: systemic chemotherapy with Age < 60
10,1,10000011,TwS,EAU High Risk with Age < 60
11,1,11000011,TwS,EAU Low Risk with Age < 60
12,1,12000011,TwS,EAU Intermediate Risk with Age < 60
1,2,1000021,TwS,Newly diagnosed prostate cancer with Age 60 - 69
2,2,2000021,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with Age 60 - 69
3,2,3000021,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with Age 60 - 69
4,2,4000021,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with Age 60 - 69
5,2,5000021,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with Age 60 - 69
7,2,7000021,TwS,Treatment category: prostatectomy surgery with Age 60 - 69
8,2,8000021,TwS,Treatment category: radiotherapy with Age 60 - 69
9,2,9000021,TwS,Treatment category: systemic chemotherapy with Age 60 - 69
10,2,10000021,TwS,EAU High Risk with Age 60 - 69
11,2,11000021,TwS,EAU Low Risk with Age 60 - 69
12,2,12000021,TwS,EAU Intermediate Risk with Age 60 - 69
1,3,1000031,TwS,Newly diagnosed prostate cancer with Age 70 - 79
2,3,2000031,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with Age 70 - 79
3,3,3000031,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with Age 70 - 79
4,3,4000031,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with Age 70 - 79
5,3,5000031,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with Age 70 - 79
7,3,7000031,TwS,Treatment category: prostatectomy surgery with Age 70 - 79
8,3,8000031,TwS,Treatment category: radiotherapy with Age 70 - 79
9,3,9000031,TwS,Treatment category: systemic chemotherapy with Age 70 - 79
10,3,10000031,TwS,EAU High Risk with Age 70 - 79
11,3,11000031,TwS,EAU Low Risk with Age 70 - 79
12,3,12000031,TwS,EAU Intermediate Risk with Age 70 - 79
1,4,1000041,TwS,Newly diagnosed prostate cancer with Age >= 80
2,4,2000041,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with Age >= 80
3,4,3000041,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with Age >= 80
4,4,4000041,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with Age >= 80
5,4,5000041,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with Age >= 80
7,4,7000041,TwS,Treatment category: prostatectomy surgery with Age >= 80
8,4,8000041,TwS,Treatment category: radiotherapy with Age >= 80
9,4,9000041,TwS,Treatment category: systemic chemotherapy with Age >= 80
10,4,10000041,TwS,EAU High Risk with Age >= 80
11,4,11000041,TwS,EAU Low Risk with Age >= 80
12,4,12000041,TwS,EAU Intermediate Risk with Age >= 80
1,36,1000361,TwS,Newly diagnosed prostate cancer with Obesity
2,36,2000361,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with Obesity
3,36,3000361,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with Obesity
4,36,4000361,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with Obesity
5,36,5000361,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with Obesity
7,36,7000361,TwS,Treatment category: prostatectomy surgery with Obesity
8,36,8000361,TwS,Treatment category: radiotherapy with Obesity
9,36,9000361,TwS,Treatment category: systemic chemotherapy with Obesity
10,36,10000361,TwS,EAU High Risk with Obesity
11,36,11000361,TwS,EAU Low Risk with Obesity
12,36,12000361,TwS,EAU Intermediate Risk with Obesity
1,37,1000371,TwS,Newly diagnosed prostate cancer with Hypertension
2,37,2000371,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with Hypertension
3,37,3000371,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with Hypertension
4,37,4000371,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with Hypertension
5,37,5000371,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with Hypertension
7,37,7000371,TwS,Treatment category: prostatectomy surgery with Hypertension
8,37,8000371,TwS,Treatment category: radiotherapy with Hypertension
9,37,9000371,TwS,Treatment category: systemic chemotherapy with Hypertension
10,37,10000371,TwS,EAU High Risk with Hypertension
11,37,11000371,TwS,EAU Low Risk with Hypertension
12,37,12000371,TwS,EAU Intermediate Risk with Hypertension
1,38,1000381,TwS,"Newly diagnosed prostate cancer with Cardiovascular events (CVE; myocardial infarction, stroke)"
2,38,2000381,TwS,"Newly diagnosed prostate cancer initiated immediate conservative trt with Cardiovascular events (CVE; myocardial infarction, stroke)"
3,38,3000381,TwS,"Newly diagnosed prostate cancer initiated delayed conservative trt with Cardiovascular events (CVE; myocardial infarction, stroke)"
4,38,4000381,TwS,"Newly diagnosed prostate cancer initiated immediate curative trt with Cardiovascular events (CVE; myocardial infarction, stroke)"
5,38,5000381,TwS,"Newly diagnosed prostate cancer initiated delayed curative trt with Cardiovascular events (CVE; myocardial infarction, stroke)"
7,38,7000381,TwS,"Treatment category: prostatectomy surgery with Cardiovascular events (CVE; myocardial infarction, stroke)"
8,38,8000381,TwS,"Treatment category: radiotherapy with Cardiovascular events (CVE; myocardial infarction, stroke)"
9,38,9000381,TwS,"Treatment category: systemic chemotherapy with Cardiovascular events (CVE; myocardial infarction, stroke)"
10,38,10000381,TwS,"EAU High Risk with Cardiovascular events (CVE; myocardial infarction, stroke)"
11,38,11000381,TwS,"EAU Low Risk with Cardiovascular events (CVE; myocardial infarction, stroke)"
12,38,12000381,TwS,"EAU Intermediate Risk with Cardiovascular events (CVE; myocardial infarction, stroke)"
1,40,1000401,TwS,Newly diagnosed prostate cancer with Venous tromboembolic events (VTE)
2,40,2000401,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with Venous tromboembolic events (VTE)
3,40,3000401,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with Venous tromboembolic events (VTE)
4,40,4000401,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with Venous tromboembolic events (VTE)
5,40,5000401,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with Venous tromboembolic events (VTE)
7,40,7000401,TwS,Treatment category: prostatectomy surgery with Venous tromboembolic events (VTE)
8,40,8000401,TwS,Treatment category: radiotherapy with Venous tromboembolic events (VTE)
9,40,9000401,TwS,Treatment category: systemic chemotherapy with Venous tromboembolic events (VTE)
10,40,10000401,TwS,EAU High Risk with Venous tromboembolic events (VTE)
11,40,11000401,TwS,EAU Low Risk with Venous tromboembolic events (VTE)
12,40,12000401,TwS,EAU Intermediate Risk with Venous tromboembolic events (VTE)
1,42,1000421,TwS,Newly diagnosed prostate cancer with Family history of Prostate cancer or family history of germline mutations
2,42,2000421,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with Family history of Prostate cancer or family history of germline mutations
3,42,3000421,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with Family history of Prostate cancer or family history of germline mutations
4,42,4000421,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with Family history of Prostate cancer or family history of germline mutations
5,42,5000421,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with Family history of Prostate cancer or family history of germline mutations
7,42,7000421,TwS,Treatment category: prostatectomy surgery with Family history of Prostate cancer or family history of germline mutations
8,42,8000421,TwS,Treatment category: radiotherapy with Family history of Prostate cancer or family history of germline mutations
9,42,9000421,TwS,Treatment category: systemic chemotherapy with Family history of Prostate cancer or family history of germline mutations
10,42,10000421,TwS,EAU High Risk with Family history of Prostate cancer or family history of germline mutations
11,42,11000421,TwS,EAU Low Risk with Family history of Prostate cancer or family history of germline mutations
12,42,12000421,TwS,EAU Intermediate Risk with Family history of Prostate cancer or family history of germline mutations
1,43,1000431,TwS,Newly diagnosed prostate cancer with PSA >20 at Diagnosis
2,43,2000431,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with PSA >20 at Diagnosis
3,43,3000431,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with PSA >20 at Diagnosis
4,43,4000431,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with PSA >20 at Diagnosis
5,43,5000431,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with PSA >20 at Diagnosis
7,43,7000431,TwS,Treatment category: prostatectomy surgery with PSA >20 at Diagnosis
8,43,8000431,TwS,Treatment category: radiotherapy with PSA >20 at Diagnosis
9,43,9000431,TwS,Treatment category: systemic chemotherapy with PSA >20 at Diagnosis
10,43,10000431,TwS,EAU High Risk with PSA >20 at Diagnosis
11,43,11000431,TwS,EAU Low Risk with PSA >20 at Diagnosis
12,43,12000431,TwS,EAU Intermediate Risk with PSA >20 at Diagnosis
1,44,1000441,TwS,Newly diagnosed prostate cancer with PSA <10 at Diagnosis
2,44,2000441,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with PSA <10 at Diagnosis
3,44,3000441,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with PSA <10 at Diagnosis
4,44,4000441,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with PSA <10 at Diagnosis
5,44,5000441,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with PSA <10 at Diagnosis
7,44,7000441,TwS,Treatment category: prostatectomy surgery with PSA <10 at Diagnosis
8,44,8000441,TwS,Treatment category: radiotherapy with PSA <10 at Diagnosis
9,44,9000441,TwS,Treatment category: systemic chemotherapy with PSA <10 at Diagnosis
10,44,10000441,TwS,EAU High Risk with PSA <10 at Diagnosis
11,44,11000441,TwS,EAU Low Risk with PSA <10 at Diagnosis
12,44,12000441,TwS,EAU Intermediate Risk with PSA <10 at Diagnosis
1,45,1000451,TwS,Newly diagnosed prostate cancer with PSA 10-20 at Diagnosis
2,45,2000451,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with PSA 10-20 at Diagnosis
3,45,3000451,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with PSA 10-20 at Diagnosis
4,45,4000451,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with PSA 10-20 at Diagnosis
5,45,5000451,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with PSA 10-20 at Diagnosis
7,45,7000451,TwS,Treatment category: prostatectomy surgery with PSA 10-20 at Diagnosis
8,45,8000451,TwS,Treatment category: radiotherapy with PSA 10-20 at Diagnosis
9,45,9000451,TwS,Treatment category: systemic chemotherapy with PSA 10-20 at Diagnosis
10,45,10000451,TwS,EAU High Risk with PSA 10-20 at Diagnosis
11,45,11000451,TwS,EAU Low Risk with PSA 10-20 at Diagnosis
12,45,12000451,TwS,EAU Intermediate Risk with PSA 10-20 at Diagnosis
1,46,1000461,TwS,Newly diagnosed prostate cancer with Grade group (Gleason score) at diagnosis 1 (3+3)
2,46,2000461,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with Grade group (Gleason score) at diagnosis 1 (3+3)
3,46,3000461,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with Grade group (Gleason score) at diagnosis 1 (3+3)
4,46,4000461,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with Grade group (Gleason score) at diagnosis 1 (3+3)
5,46,5000461,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with Grade group (Gleason score) at diagnosis 1 (3+3)
7,46,7000461,TwS,Treatment category: prostatectomy surgery with Grade group (Gleason score) at diagnosis 1 (3+3)
8,46,8000461,TwS,Treatment category: radiotherapy with Grade group (Gleason score) at diagnosis 1 (3+3)
9,46,9000461,TwS,Treatment category: systemic chemotherapy with Grade group (Gleason score) at diagnosis 1 (3+3)
10,46,10000461,TwS,EAU High Risk with Grade group (Gleason score) at diagnosis 1 (3+3)
11,46,11000461,TwS,EAU Low Risk with Grade group (Gleason score) at diagnosis 1 (3+3)
12,46,12000461,TwS,EAU Intermediate Risk with Grade group (Gleason score) at diagnosis 1 (3+3)
1,47,1000471,TwS,Newly diagnosed prostate cancer with Grade group (Gleason score) at diagnosis 2 (3+4)
2,47,2000471,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with Grade group (Gleason score) at diagnosis 2 (3+4)
3,47,3000471,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with Grade group (Gleason score) at diagnosis 2 (3+4)
4,47,4000471,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with Grade group (Gleason score) at diagnosis 2 (3+4)
5,47,5000471,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with Grade group (Gleason score) at diagnosis 2 (3+4)
7,47,7000471,TwS,Treatment category: prostatectomy surgery with Grade group (Gleason score) at diagnosis 2 (3+4)
8,47,8000471,TwS,Treatment category: radiotherapy with Grade group (Gleason score) at diagnosis 2 (3+4)
9,47,9000471,TwS,Treatment category: systemic chemotherapy with Grade group (Gleason score) at diagnosis 2 (3+4)
10,47,10000471,TwS,EAU High Risk with Grade group (Gleason score) at diagnosis 2 (3+4)
11,47,11000471,TwS,EAU Low Risk with Grade group (Gleason score) at diagnosis 2 (3+4)
12,47,12000471,TwS,EAU Intermediate Risk with Grade group (Gleason score) at diagnosis 2 (3+4)
1,48,1000481,TwS,Newly diagnosed prostate cancer with Grade group (Gleason score) at diagnosis 3 (4+3)
2,48,2000481,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with Grade group (Gleason score) at diagnosis 3 (4+3)
3,48,3000481,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with Grade group (Gleason score) at diagnosis 3 (4+3)
4,48,4000481,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with Grade group (Gleason score) at diagnosis 3 (4+3)
5,48,5000481,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with Grade group (Gleason score) at diagnosis 3 (4+3)
7,48,7000481,TwS,Treatment category: prostatectomy surgery with Grade group (Gleason score) at diagnosis 3 (4+3)
8,48,8000481,TwS,Treatment category: radiotherapy with Grade group (Gleason score) at diagnosis 3 (4+3)
9,48,9000481,TwS,Treatment category: systemic chemotherapy with Grade group (Gleason score) at diagnosis 3 (4+3)
10,48,10000481,TwS,EAU High Risk with Grade group (Gleason score) at diagnosis 3 (4+3)
11,48,11000481,TwS,EAU Low Risk with Grade group (Gleason score) at diagnosis 3 (4+3)
12,48,12000481,TwS,EAU Intermediate Risk with Grade group (Gleason score) at diagnosis 3 (4+3)
1,49,1000491,TwS,Newly diagnosed prostate cancer with Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
2,49,2000491,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
3,49,3000491,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
4,49,4000491,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
5,49,5000491,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
7,49,7000491,TwS,Treatment category: prostatectomy surgery with Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
8,49,8000491,TwS,Treatment category: radiotherapy with Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
9,49,9000491,TwS,Treatment category: systemic chemotherapy with Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
10,49,10000491,TwS,EAU High Risk with Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
11,49,11000491,TwS,EAU Low Risk with Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
12,49,12000491,TwS,EAU Intermediate Risk with Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
1,50,1000501,TwS,Newly diagnosed prostate cancer with Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
2,50,2000501,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
3,50,3000501,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
4,50,4000501,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
5,50,5000501,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
7,50,7000501,TwS,Treatment category: prostatectomy surgery with Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
8,50,8000501,TwS,Treatment category: radiotherapy with Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
9,50,9000501,TwS,Treatment category: systemic chemotherapy with Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
10,50,10000501,TwS,EAU High Risk with Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
11,50,11000501,TwS,EAU Low Risk with Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
12,50,12000501,TwS,EAU Intermediate Risk with Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
1,51,1000511,TwS,"Newly diagnosed prostate cancer with EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
2,51,2000511,TwS,"Newly diagnosed prostate cancer initiated immediate conservative trt with EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
3,51,3000511,TwS,"Newly diagnosed prostate cancer initiated delayed conservative trt with EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
4,51,4000511,TwS,"Newly diagnosed prostate cancer initiated immediate curative trt with EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
5,51,5000511,TwS,"Newly diagnosed prostate cancer initiated delayed curative trt with EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
7,51,7000511,TwS,"Treatment category: prostatectomy surgery with EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
8,51,8000511,TwS,"Treatment category: radiotherapy with EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
9,51,9000511,TwS,"Treatment category: systemic chemotherapy with EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
10,51,10000511,TwS,"EAU High Risk with EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
11,51,11000511,TwS,"EAU Low Risk with EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
12,51,12000511,TwS,"EAU Intermediate Risk with EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
1,52,1000521,TwS,Newly diagnosed prostate cancer with EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
2,52,2000521,TwS,Newly diagnosed prostate cancer initiated immediate conservative trt with EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
3,52,3000521,TwS,Newly diagnosed prostate cancer initiated delayed conservative trt with EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
4,52,4000521,TwS,Newly diagnosed prostate cancer initiated immediate curative trt with EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
5,52,5000521,TwS,Newly diagnosed prostate cancer initiated delayed curative trt with EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
7,52,7000521,TwS,Treatment category: prostatectomy surgery with EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
8,52,8000521,TwS,Treatment category: radiotherapy with EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
9,52,9000521,TwS,Treatment category: systemic chemotherapy with EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
10,52,10000521,TwS,EAU High Risk with EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
11,52,11000521,TwS,EAU Low Risk with EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
12,52,12000521,TwS,EAU Intermediate Risk with EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
1,53,1000531,TwS,"Newly diagnosed prostate cancer with EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
2,53,2000531,TwS,"Newly diagnosed prostate cancer initiated immediate conservative trt with EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
3,53,3000531,TwS,"Newly diagnosed prostate cancer initiated delayed conservative trt with EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
4,53,4000531,TwS,"Newly diagnosed prostate cancer initiated immediate curative trt with EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
5,53,5000531,TwS,"Newly diagnosed prostate cancer initiated delayed curative trt with EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
7,53,7000531,TwS,"Treatment category: prostatectomy surgery with EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
8,53,8000531,TwS,"Treatment category: radiotherapy with EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
9,53,9000531,TwS,"Treatment category: systemic chemotherapy with EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
10,53,10000531,TwS,"EAU High Risk with EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
11,53,11000531,TwS,"EAU Low Risk with EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
12,53,12000531,TwS,"EAU Intermediate Risk with EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
1,36,1000362,TwoS,Newly diagnosed prostate cancer without Obesity
2,36,2000362,TwoS,Newly diagnosed prostate cancer initiated immediate conservative trt without Obesity
3,36,3000362,TwoS,Newly diagnosed prostate cancer initiated delayed conservative trt without Obesity
4,36,4000362,TwoS,Newly diagnosed prostate cancer initiated immediate curative trt without Obesity
5,36,5000362,TwoS,Newly diagnosed prostate cancer initiated delayed curative trt without Obesity
7,36,7000362,TwoS,Treatment category: prostatectomy surgery without Obesity
8,36,8000362,TwoS,Treatment category: radiotherapy without Obesity
9,36,9000362,TwoS,Treatment category: systemic chemotherapy without Obesity
10,36,10000362,TwoS,EAU High Risk without Obesity
11,36,11000362,TwoS,EAU Low Risk without Obesity
12,36,12000362,TwoS,EAU Intermediate Risk without Obesity
1,37,1000372,TwoS,Newly diagnosed prostate cancer without Hypertension
2,37,2000372,TwoS,Newly diagnosed prostate cancer initiated immediate conservative trt without Hypertension
3,37,3000372,TwoS,Newly diagnosed prostate cancer initiated delayed conservative trt without Hypertension
4,37,4000372,TwoS,Newly diagnosed prostate cancer initiated immediate curative trt without Hypertension
5,37,5000372,TwoS,Newly diagnosed prostate cancer initiated delayed curative trt without Hypertension
7,37,7000372,TwoS,Treatment category: prostatectomy surgery without Hypertension
8,37,8000372,TwoS,Treatment category: radiotherapy without Hypertension
9,37,9000372,TwoS,Treatment category: systemic chemotherapy without Hypertension
10,37,10000372,TwoS,EAU High Risk without Hypertension
11,37,11000372,TwoS,EAU Low Risk without Hypertension
12,37,12000372,TwoS,EAU Intermediate Risk without Hypertension
1,38,1000382,TwoS,"Newly diagnosed prostate cancer without Cardiovascular events (CVE; myocardial infarction, stroke)"
2,38,2000382,TwoS,"Newly diagnosed prostate cancer initiated immediate conservative trt without Cardiovascular events (CVE; myocardial infarction, stroke)"
3,38,3000382,TwoS,"Newly diagnosed prostate cancer initiated delayed conservative trt without Cardiovascular events (CVE; myocardial infarction, stroke)"
4,38,4000382,TwoS,"Newly diagnosed prostate cancer initiated immediate curative trt without Cardiovascular events (CVE; myocardial infarction, stroke)"
5,38,5000382,TwoS,"Newly diagnosed prostate cancer initiated delayed curative trt without Cardiovascular events (CVE; myocardial infarction, stroke)"
7,38,7000382,TwoS,"Treatment category: prostatectomy surgery without Cardiovascular events (CVE; myocardial infarction, stroke)"
8,38,8000382,TwoS,"Treatment category: radiotherapy without Cardiovascular events (CVE; myocardial infarction, stroke)"
9,38,9000382,TwoS,"Treatment category: systemic chemotherapy without Cardiovascular events (CVE; myocardial infarction, stroke)"
10,38,10000382,TwoS,"EAU High Risk without Cardiovascular events (CVE; myocardial infarction, stroke)"
11,38,11000382,TwoS,"EAU Low Risk without Cardiovascular events (CVE; myocardial infarction, stroke)"
12,38,12000382,TwoS,"EAU Intermediate Risk without Cardiovascular events (CVE; myocardial infarction, stroke)"
1,40,1000402,TwoS,Newly diagnosed prostate cancer without Venous tromboembolic events (VTE)
2,40,2000402,TwoS,Newly diagnosed prostate cancer initiated immediate conservative trt without Venous tromboembolic events (VTE)
3,40,3000402,TwoS,Newly diagnosed prostate cancer initiated delayed conservative trt without Venous tromboembolic events (VTE)
4,40,4000402,TwoS,Newly diagnosed prostate cancer initiated immediate curative trt without Venous tromboembolic events (VTE)
5,40,5000402,TwoS,Newly diagnosed prostate cancer initiated delayed curative trt without Venous tromboembolic events (VTE)
7,40,7000402,TwoS,Treatment category: prostatectomy surgery without Venous tromboembolic events (VTE)
8,40,8000402,TwoS,Treatment category: radiotherapy without Venous tromboembolic events (VTE)
9,40,9000402,TwoS,Treatment category: systemic chemotherapy without Venous tromboembolic events (VTE)
10,40,10000402,TwoS,EAU High Risk without Venous tromboembolic events (VTE)
11,40,11000402,TwoS,EAU Low Risk without Venous tromboembolic events (VTE)
12,40,12000402,TwoS,EAU Intermediate Risk without Venous tromboembolic events (VTE)
1,42,1000422,TwoS,Newly diagnosed prostate cancer without Family history of Prostate cancer or family history of germline mutations
2,42,2000422,TwoS,Newly diagnosed prostate cancer initiated immediate conservative trt without Family history of Prostate cancer or family history of germline mutations
3,42,3000422,TwoS,Newly diagnosed prostate cancer initiated delayed conservative trt without Family history of Prostate cancer or family history of germline mutations
4,42,4000422,TwoS,Newly diagnosed prostate cancer initiated immediate curative trt without Family history of Prostate cancer or family history of germline mutations
5,42,5000422,TwoS,Newly diagnosed prostate cancer initiated delayed curative trt without Family history of Prostate cancer or family history of germline mutations
7,42,7000422,TwoS,Treatment category: prostatectomy surgery without Family history of Prostate cancer or family history of germline mutations
8,42,8000422,TwoS,Treatment category: radiotherapy without Family history of Prostate cancer or family history of germline mutations
9,42,9000422,TwoS,Treatment category: systemic chemotherapy without Family history of Prostate cancer or family history of germline mutations
10,42,10000422,TwoS,EAU High Risk without Family history of Prostate cancer or family history of germline mutations
11,42,11000422,TwoS,EAU Low Risk without Family history of Prostate cancer or family history of germline mutations
12,42,12000422,TwoS,EAU Intermediate Risk without Family history of Prostate cancer or family history of germline mutations
1,43,1000432,TwoS,Newly diagnosed prostate cancer without PSA >20 at Diagnosis
2,43,2000432,TwoS,Newly diagnosed prostate cancer initiated immediate conservative trt without PSA >20 at Diagnosis
3,43,3000432,TwoS,Newly diagnosed prostate cancer initiated delayed conservative trt without PSA >20 at Diagnosis
4,43,4000432,TwoS,Newly diagnosed prostate cancer initiated immediate curative trt without PSA >20 at Diagnosis
5,43,5000432,TwoS,Newly diagnosed prostate cancer initiated delayed curative trt without PSA >20 at Diagnosis
7,43,7000432,TwoS,Treatment category: prostatectomy surgery without PSA >20 at Diagnosis
8,43,8000432,TwoS,Treatment category: radiotherapy without PSA >20 at Diagnosis
9,43,9000432,TwoS,Treatment category: systemic chemotherapy without PSA >20 at Diagnosis
10,43,10000432,TwoS,EAU High Risk without PSA >20 at Diagnosis
11,43,11000432,TwoS,EAU Low Risk without PSA >20 at Diagnosis
12,43,12000432,TwoS,EAU Intermediate Risk without PSA >20 at Diagnosis
1,44,1000442,TwoS,Newly diagnosed prostate cancer without PSA <10 at Diagnosis
2,44,2000442,TwoS,Newly diagnosed prostate cancer initiated immediate conservative trt without PSA <10 at Diagnosis
3,44,3000442,TwoS,Newly diagnosed prostate cancer initiated delayed conservative trt without PSA <10 at Diagnosis
4,44,4000442,TwoS,Newly diagnosed prostate cancer initiated immediate curative trt without PSA <10 at Diagnosis
5,44,5000442,TwoS,Newly diagnosed prostate cancer initiated delayed curative trt without PSA <10 at Diagnosis
7,44,7000442,TwoS,Treatment category: prostatectomy surgery without PSA <10 at Diagnosis
8,44,8000442,TwoS,Treatment category: radiotherapy without PSA <10 at Diagnosis
9,44,9000442,TwoS,Treatment category: systemic chemotherapy without PSA <10 at Diagnosis
10,44,10000442,TwoS,EAU High Risk without PSA <10 at Diagnosis
11,44,11000442,TwoS,EAU Low Risk without PSA <10 at Diagnosis
12,44,12000442,TwoS,EAU Intermediate Risk without PSA <10 at Diagnosis
1,45,1000452,TwoS,Newly diagnosed prostate cancer without PSA 10-20 at Diagnosis
2,45,2000452,TwoS,Newly diagnosed prostate cancer initiated immediate conservative trt without PSA 10-20 at Diagnosis
3,45,3000452,TwoS,Newly diagnosed prostate cancer initiated delayed conservative trt without PSA 10-20 at Diagnosis
4,45,4000452,TwoS,Newly diagnosed prostate cancer initiated immediate curative trt without PSA 10-20 at Diagnosis
5,45,5000452,TwoS,Newly diagnosed prostate cancer initiated delayed curative trt without PSA 10-20 at Diagnosis
7,45,7000452,TwoS,Treatment category: prostatectomy surgery without PSA 10-20 at Diagnosis
8,45,8000452,TwoS,Treatment category: radiotherapy without PSA 10-20 at Diagnosis
9,45,9000452,TwoS,Treatment category: systemic chemotherapy without PSA 10-20 at Diagnosis
10,45,10000452,TwoS,EAU High Risk without PSA 10-20 at Diagnosis
11,45,11000452,TwoS,EAU Low Risk without PSA 10-20 at Diagnosis
12,45,12000452,TwoS,EAU Intermediate Risk without PSA 10-20 at Diagnosis
1,46,1000462,TwoS,Newly diagnosed prostate cancer without Grade group (Gleason score) at diagnosis 1 (3+3)
2,46,2000462,TwoS,Newly diagnosed prostate cancer initiated immediate conservative trt without Grade group (Gleason score) at diagnosis 1 (3+3)
3,46,3000462,TwoS,Newly diagnosed prostate cancer initiated delayed conservative trt without Grade group (Gleason score) at diagnosis 1 (3+3)
4,46,4000462,TwoS,Newly diagnosed prostate cancer initiated immediate curative trt without Grade group (Gleason score) at diagnosis 1 (3+3)
5,46,5000462,TwoS,Newly diagnosed prostate cancer initiated delayed curative trt without Grade group (Gleason score) at diagnosis 1 (3+3)
7,46,7000462,TwoS,Treatment category: prostatectomy surgery without Grade group (Gleason score) at diagnosis 1 (3+3)
8,46,8000462,TwoS,Treatment category: radiotherapy without Grade group (Gleason score) at diagnosis 1 (3+3)
9,46,9000462,TwoS,Treatment category: systemic chemotherapy without Grade group (Gleason score) at diagnosis 1 (3+3)
10,46,10000462,TwoS,EAU High Risk without Grade group (Gleason score) at diagnosis 1 (3+3)
11,46,11000462,TwoS,EAU Low Risk without Grade group (Gleason score) at diagnosis 1 (3+3)
12,46,12000462,TwoS,EAU Intermediate Risk without Grade group (Gleason score) at diagnosis 1 (3+3)
1,47,1000472,TwoS,Newly diagnosed prostate cancer without Grade group (Gleason score) at diagnosis 2 (3+4)
2,47,2000472,TwoS,Newly diagnosed prostate cancer initiated immediate conservative trt without Grade group (Gleason score) at diagnosis 2 (3+4)
3,47,3000472,TwoS,Newly diagnosed prostate cancer initiated delayed conservative trt without Grade group (Gleason score) at diagnosis 2 (3+4)
4,47,4000472,TwoS,Newly diagnosed prostate cancer initiated immediate curative trt without Grade group (Gleason score) at diagnosis 2 (3+4)
5,47,5000472,TwoS,Newly diagnosed prostate cancer initiated delayed curative trt without Grade group (Gleason score) at diagnosis 2 (3+4)
7,47,7000472,TwoS,Treatment category: prostatectomy surgery without Grade group (Gleason score) at diagnosis 2 (3+4)
8,47,8000472,TwoS,Treatment category: radiotherapy without Grade group (Gleason score) at diagnosis 2 (3+4)
9,47,9000472,TwoS,Treatment category: systemic chemotherapy without Grade group (Gleason score) at diagnosis 2 (3+4)
10,47,10000472,TwoS,EAU High Risk without Grade group (Gleason score) at diagnosis 2 (3+4)
11,47,11000472,TwoS,EAU Low Risk without Grade group (Gleason score) at diagnosis 2 (3+4)
12,47,12000472,TwoS,EAU Intermediate Risk without Grade group (Gleason score) at diagnosis 2 (3+4)
1,48,1000482,TwoS,Newly diagnosed prostate cancer without Grade group (Gleason score) at diagnosis 3 (4+3)
2,48,2000482,TwoS,Newly diagnosed prostate cancer initiated immediate conservative trt without Grade group (Gleason score) at diagnosis 3 (4+3)
3,48,3000482,TwoS,Newly diagnosed prostate cancer initiated delayed conservative trt without Grade group (Gleason score) at diagnosis 3 (4+3)
4,48,4000482,TwoS,Newly diagnosed prostate cancer initiated immediate curative trt without Grade group (Gleason score) at diagnosis 3 (4+3)
5,48,5000482,TwoS,Newly diagnosed prostate cancer initiated delayed curative trt without Grade group (Gleason score) at diagnosis 3 (4+3)
7,48,7000482,TwoS,Treatment category: prostatectomy surgery without Grade group (Gleason score) at diagnosis 3 (4+3)
8,48,8000482,TwoS,Treatment category: radiotherapy without Grade group (Gleason score) at diagnosis 3 (4+3)
9,48,9000482,TwoS,Treatment category: systemic chemotherapy without Grade group (Gleason score) at diagnosis 3 (4+3)
10,48,10000482,TwoS,EAU High Risk without Grade group (Gleason score) at diagnosis 3 (4+3)
11,48,11000482,TwoS,EAU Low Risk without Grade group (Gleason score) at diagnosis 3 (4+3)
12,48,12000482,TwoS,EAU Intermediate Risk without Grade group (Gleason score) at diagnosis 3 (4+3)
1,49,1000492,TwoS,Newly diagnosed prostate cancer without Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
2,49,2000492,TwoS,Newly diagnosed prostate cancer initiated immediate conservative trt without Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
3,49,3000492,TwoS,Newly diagnosed prostate cancer initiated delayed conservative trt without Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
4,49,4000492,TwoS,Newly diagnosed prostate cancer initiated immediate curative trt without Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
5,49,5000492,TwoS,Newly diagnosed prostate cancer initiated delayed curative trt without Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
7,49,7000492,TwoS,Treatment category: prostatectomy surgery without Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
8,49,8000492,TwoS,Treatment category: radiotherapy without Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
9,49,9000492,TwoS,Treatment category: systemic chemotherapy without Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
10,49,10000492,TwoS,EAU High Risk without Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
11,49,11000492,TwoS,EAU Low Risk without Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
12,49,12000492,TwoS,EAU Intermediate Risk without Grade group (Gleason score) at diagnosis 4 (4+4 OR 3+5 OR 5+3)
1,50,1000502,TwoS,Newly diagnosed prostate cancer without Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
2,50,2000502,TwoS,Newly diagnosed prostate cancer initiated immediate conservative trt without Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
3,50,3000502,TwoS,Newly diagnosed prostate cancer initiated delayed conservative trt without Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
4,50,4000502,TwoS,Newly diagnosed prostate cancer initiated immediate curative trt without Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
5,50,5000502,TwoS,Newly diagnosed prostate cancer initiated delayed curative trt without Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
7,50,7000502,TwoS,Treatment category: prostatectomy surgery without Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
8,50,8000502,TwoS,Treatment category: radiotherapy without Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
9,50,9000502,TwoS,Treatment category: systemic chemotherapy without Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
10,50,10000502,TwoS,EAU High Risk without Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
11,50,11000502,TwoS,EAU Low Risk without Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
12,50,12000502,TwoS,EAU Intermediate Risk without Grade group (Gleason score) at diagnosis 5 (5+5 OR 4+5 OR 5+4)
1,51,1000512,TwoS,"Newly diagnosed prostate cancer without EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
2,51,2000512,TwoS,"Newly diagnosed prostate cancer initiated immediate conservative trt without EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
3,51,3000512,TwoS,"Newly diagnosed prostate cancer initiated delayed conservative trt without EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
4,51,4000512,TwoS,"Newly diagnosed prostate cancer initiated immediate curative trt without EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
5,51,5000512,TwoS,"Newly diagnosed prostate cancer initiated delayed curative trt without EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
7,51,7000512,TwoS,"Treatment category: prostatectomy surgery without EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
8,51,8000512,TwoS,"Treatment category: radiotherapy without EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
9,51,9000512,TwoS,"Treatment category: systemic chemotherapy without EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
10,51,10000512,TwoS,"EAU High Risk without EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
11,51,11000512,TwoS,"EAU Low Risk without EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
12,51,12000512,TwoS,"EAU Intermediate Risk without EAU risk group at diagnosis low-risk (PSA <10 ng/ml AND (Gleason score 6 OR grade group 1) AND c1/cT2a),"
1,52,1000522,TwoS,Newly diagnosed prostate cancer without EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
2,52,2000522,TwoS,Newly diagnosed prostate cancer initiated immediate conservative trt without EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
3,52,3000522,TwoS,Newly diagnosed prostate cancer initiated delayed conservative trt without EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
4,52,4000522,TwoS,Newly diagnosed prostate cancer initiated immediate curative trt without EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
5,52,5000522,TwoS,Newly diagnosed prostate cancer initiated delayed curative trt without EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
7,52,7000522,TwoS,Treatment category: prostatectomy surgery without EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
8,52,8000522,TwoS,Treatment category: radiotherapy without EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
9,52,9000522,TwoS,Treatment category: systemic chemotherapy without EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
10,52,10000522,TwoS,EAU High Risk without EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
11,52,11000522,TwoS,EAU Low Risk without EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
12,52,12000522,TwoS,EAU Intermediate Risk without EAU risk group at diagnosis intermediate-risk (PSA 10-20 ng/ml OR (Gleason score 7 OR grade group 2-3) OR cT2b)
1,53,1000532,TwoS,"Newly diagnosed prostate cancer without EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
2,53,2000532,TwoS,"Newly diagnosed prostate cancer initiated immediate conservative trt without EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
3,53,3000532,TwoS,"Newly diagnosed prostate cancer initiated delayed conservative trt without EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
4,53,4000532,TwoS,"Newly diagnosed prostate cancer initiated immediate curative trt without EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
5,53,5000532,TwoS,"Newly diagnosed prostate cancer initiated delayed curative trt without EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
7,53,7000532,TwoS,"Treatment category: prostatectomy surgery without EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
8,53,8000532,TwoS,"Treatment category: radiotherapy without EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
9,53,9000532,TwoS,"Treatment category: systemic chemotherapy without EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
10,53,10000532,TwoS,"EAU High Risk without EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
11,53,11000532,TwoS,"EAU Low Risk without EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
12,53,12000532,TwoS,"EAU Intermediate Risk without EAU risk group at diagnosis high-risk (PSA >20 ng/ml OR (Gleason score 8-10 OR grade group 4-5) OR cT2c or cT3, cT4)"
